An Evaluation Of Boston Scientific Corp (NYSE: BSX) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

BSX belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. The current market capitalization of Boston Scientific Corp is $152.09B. A total of 6.45 million shares were traded on the day, compared to an average of 7.45M shares.

In the most recent transaction, Fitzgerald Joseph Michael sold 50,000 shares of BSX for 104.63 per share on Aug 01 ’25. After the transaction, the EVP & Group Pres, Cardiology now owns 178,342 company shares. In a previous transaction on Aug 01 ’25, Butcher Arthur C sold 17,313 shares at 104.63 per share. BSX shares that EVP& Grp Pres, MedSurg & APAC owns now total 23,600.

Among the insiders who bought shares, ARTHUR C BUTCHER acquired of 17,313 shares on Aug 01 ’25 at a per-share price of $104.63. In another insider transaction, JOSEPH M FITZGERALD bought 50,000 shares at $104.63 per share on Aug 01 ’25.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BSX has a high of $108.94 and a low of $75.44.

As of this writing, BSX has an earnings estimate of $0.71 per share for the current quarter. EPS was calculated based on a consensus of 27.0 estimates, with a high estimate of $0.75 per share and a lower estimate of $0.7. The company reported an EPS of $0.63 in the last quarter

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $15.14, while its Total Shareholder’s Equity was $16.62B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.84.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.